What is the recommended protocol for switching a patient from sertraline 150 mg daily to lamotrigine 100 mg daily?

Switching from Sertraline 150mg to Lamotrigine 100mg

You cannot directly "switch" from sertraline to lamotrigine—these medications treat fundamentally different conditions and require completely separate management strategies. Sertraline is an SSRI antidepressant, while lamotrigine is an antiepileptic/mood stabilizer, and they are not interchangeable therapies.

Critical Clarification Needed

Before proceeding, you must determine:

• Why is lamotrigine being started? (bipolar disorder, epilepsy, mood stabilization)
• Why is sertraline being discontinued? (lack of efficacy, adverse effects, diagnostic revision)
• What is the underlying diagnosis? This fundamentally changes the approach.

If Both Medications Are Indicated (Most Likely Scenario)

Starting Lamotrigine

Lamotrigine requires extremely slow titration to minimize the risk of serious skin rash (Stevens-Johnson syndrome). 1

Standard lamotrigine titration protocol:

• Weeks 1-2: 25 mg daily
• Weeks 3-4: 50 mg daily
• Week 5: 100 mg daily (target dose)
• Increase by 25-50 mg every 1-2 weeks if higher doses needed 1

Critical warning: Faster titration significantly increases rash risk. The incidence of rash ranges from 10-17% even with proper titration 1. Any rash requires immediate discontinuation and medical evaluation.

Discontinuing Sertraline

Sertraline is specifically associated with discontinuation syndrome and must be tapered gradually. 2

For sertraline 150 mg, recommended taper:

• Week 1-2: Reduce to 100 mg daily
• Week 3-4: Reduce to 50 mg daily
• Week 5-6: Reduce to 25 mg daily
• Week 7: Discontinue

The taper should occur over 10-14 days minimum 3, though 4-6 weeks is safer for higher doses like 150 mg 4. Patients at higher risk of withdrawal may require even slower tapers over many weeks 4.

Discontinuation syndrome symptoms include: dizziness, fatigue, nausea, headaches, insomnia, sensory disturbances, paresthesias, anxiety, and irritability 2.

Timing Strategy

Option 1 (Conservative - Recommended):

• Start lamotrigine titration immediately
• Begin sertraline taper after lamotrigine reaches 50-100 mg (week 3-5)
• This allows lamotrigine to provide therapeutic coverage before fully discontinuing sertraline

Option 2 (If sertraline must stop urgently):

• Begin both simultaneously
• Accept that there will be a therapeutic gap since lamotrigine takes 4-5 weeks to reach 100 mg

Drug Interaction Consideration

Important: There is conflicting evidence about sertraline-lamotrigine interaction. One case report showed sertraline doubled lamotrigine levels 5, while a larger retrospective study found no clinically significant interaction 6. Monitor for lamotrigine toxicity symptoms (ataxia, dizziness, diplopia, somnolence) during overlap 1, though this interaction appears uncommon.

Monitoring Requirements

During the transition:

• Weekly contact (phone or in-person) for first 4 weeks to assess for rash, withdrawal symptoms, and psychiatric stability 7
• Immediate evaluation for any rash development
• Monitor for worsening mood, suicidal ideation, or behavioral activation 2
• Assess discontinuation syndrome symptoms at each sertraline dose reduction

Common Pitfalls to Avoid

1. Never abruptly stop sertraline 150 mg—this dose carries significant withdrawal risk
2. Never rapid-titrate lamotrigine—rash risk is dose-dependent and titration-speed dependent
3. Do not assume these medications are equivalent—clarify the clinical indication for each
4. Do not start lamotrigine at 100 mg—this violates all safety protocols